Bob Roda- President and Chief Executive Officer, Hemosonics

Bob Roda is the President and CEO, of Hemosonics, bringing more than 25 years of global experience developing and commercializing innovative diagnostic and medical device products and services. Prior to HemoSonics, Bob Roda served as President and CEO of Menarini Silicon Biosystems, Inc, a diagnostic and biotech company focused on the use of liquid biopsy and predictive diagnostic tests for the treatment of cancer patients. Prior to that position he was Vice President and General Manager at Becton Dickinson where he led the medical and procedural solutions business in the US. From 1998-2012, Bob held positions of increasing responsibility at Johnson & Johnson in both the medical device and diagnostic sectors, with his last role being WW VP Marketing in Immunohematology, Donor Screening and Clinical Laboratories at Ortho Clinical Diagnostics, a J&J company. Bob earned a Bachelor of Arts degree in Economics from the University of Rhode Island and completed post graduate course work at Kellogg Graduate School of Management.

Teva, Sanofi, Biomarin, Janssen and Others Recognized at eyeforpharma Awards

Life Science Industry Outlook: 2019 In Review and 2020 Trends to Watch